Clinical Trials Logo

Filter by:
NCT ID: NCT04785053 Active, not recruiting - Alzheimer Disease Clinical Trials

Memory Functions in Mild Alzheimer's Disease

MemStim-lab
Start date: June 22, 2020
Phase: N/A
Study type: Interventional

The overall objective of this project is to examine the effects of non-invasive brain stimulation on episodic memory performance

NCT ID: NCT04784767 Active, not recruiting - Clinical trials for SARS-CoV-2 Infection

SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults

Start date: April 5, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety, reactogenicity, and immune response of the SpFN COVID-19 vaccine with Army Liposomal Formulation QS21 (ALFQ) adjuvant in healthy adults ages 18-55.

NCT ID: NCT04784715 Active, not recruiting - Clinical trials for Breast Cancer; HER2-positive; Metastatic

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Start date: April 26, 2021
Phase: Phase 3
Study type: Interventional

The study will evaluate the efficacy and safety of trastuzumab deruxtecan (also known as T-DXd, DS-8201a), either alone or in combination with pertuzumab, in treating patients with Human epidermal growth factor receptor 2 (HER2)-positive breast cancer as a first line of treatment in the metastatic setting.

NCT ID: NCT04784611 Active, not recruiting - Disabled Persons Clinical Trials

Our Peers - Empowerment and Navigational Support

OP-ENS
Start date: April 16, 2018
Phase: N/A
Study type: Interventional

People with physical disabilities experience well documented barriers to healthcare access, quality and outcomes. The purpose of this study is to implement and evaluate a 12-month peer health navigator intervention (called Our Peer-Empowerment and Navigational Support) designed to help Medicaid beneficiaries with physical disabilities break down barriers to care through a systematic process of 1) rapport building, 2) identification of healthcare needs and priorities, 3) identification of barriers and supports, 4) co-creation of goal and action plans, and 5) provision of social and informational support. It is hypothesized that people in the interventional trial will experience: improved patient activation, increased social support, increased access to care, increased quality of care, and increased health outcomes compared to people in the control group.

NCT ID: NCT04784429 Active, not recruiting - Clinical trials for Lower Limb Amputation Above Knee (Injury)

Assessing Outcomes With Microprocessor Knee Utilization in a K2 Population

ASCENT K2
Start date: June 11, 2021
Phase: N/A
Study type: Interventional

Two-phased randomized controlled trial comparing the impact of microprocessor controlled knee prostheses (MPK) with the impact of non-microprocessor controlled knee prostheses (NPMK) in patients with a transfemoral/knee disarticulation level amputation categorized as K2 ambulators.

NCT ID: NCT04784351 Active, not recruiting - Asthma Clinical Trials

Prediction of Expected Length of Hospital Stay Using Machine Learning

Start date: March 20, 2021
Phase:
Study type: Observational

This is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict length of stay throughout a patient's admission. This algorithm was then validated in a validation cohort.

NCT ID: NCT04784247 Active, not recruiting - Advanced Sarcoma Clinical Trials

Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma

Start date: March 18, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out whether combining the study drugs, lenvatinib and pembrolizumab, is a safe and effective treatment for metastatic soft tissue sarcomas that cannot be removed with surgery.

NCT ID: NCT04784143 Active, not recruiting - PTSD Clinical Trials

Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD

MPVA6
Start date: November 8, 2021
Phase: Phase 2
Study type: Interventional

This open-label, randomized study will assess the comparative effectiveness of two versus three active MDMA-assisted sessions in U.S. military veterans with at least moderate chronic PTSD treated in an outpatient VA treatment clinic.

NCT ID: NCT04784065 Active, not recruiting - Hand Osteoarthritis Clinical Trials

A Pilot Randomized Controlled Trial for Hand Osteoarthritis

Start date: February 11, 2021
Phase: N/A
Study type: Interventional

This is a study involving people receiving care at the Michael E. DeBakey VA Medical Center, Houston Texas. We are studying people who have hand osteoarthritis (the most common form of arthritis that involves the hand) and testing treatments for the condition with the hope that we can help to improve hand pain as well as limit the damage that occurs related to the arthritis. People who choose to participate, are randomly assigned to one of two treatments, both expected to be helpful.

NCT ID: NCT04783428 Active, not recruiting - Clinical trials for Tumor-induced Osteomalacia (TIO)

Tumor-induced Osteomalacia Disease Monitoring Program

Start date: January 31, 2022
Phase:
Study type: Observational

The objectives of this observational study are to assess the long-term safety and long-term effectiveness of burosumab in patients with TIO who are being treated with burosumab as prescribed by their physician and to monitor the course of the underlying phosphaturic mesenchymal tumor (PMT) overtime in patients with TIO irrespective of their treatment status.